HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autologous peripheral stem-cell transplantation after intensive chemotherapy in a case of CD30 (Ki-1)-positive anaplastic large-cell lymphoma.

Abstract
Simultaneous treatment with peripheral blood stem-cell (PBSC) transplantation and intensive chemotherapy was evaluated in a case of non-Hodgkin's lymphoma (NHL) with poor prognosis. A 59-year-old male diagnosed with a high-grade, anaplastic large-cell (Ki-1) NHL, involving fractures in the left hip, underwent computed tomography and gallium scintigram surveillance. The patient received chemotherapy with epirubicin hydrochloride, cyclophosphamide, vincristine and prednisolone, and the fractured hip bone was repaired following the first course of chemotherapy. After the second and third courses of chemotherapy, PBSCs were harvested and cryopreserved. The patient then received a further course of chemotherapy and PBSC transplantation was conducted using infused cells consisting of 9.63 x 10(6)/kg CD34 cells and 2.24 x 10(5)/kg granulocyte macrophage colony-forming units. Recovery of platelet and white blood cell counts occurred 10 and 8 days, respectively, after PBSC infusion and the patient remains well.
AuthorsT Tsuda, M Matsunami, K Nakayama, J Hara, R Sakaguchi, N Katayama, Y Okamoto, K Ota
JournalThe Journal of international medical research (J Int Med Res) 2001 Sep-Oct Vol. 29 Issue 5 Pg. 425-31 ISSN: 0300-0605 [Print] England
PMID11725830 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Epirubicin
  • Vincristine
  • Cyclophosphamide
  • Prednisolone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage)
  • Epirubicin (administration & dosage)
  • Follow-Up Studies
  • Humans
  • Lymphoma, Large-Cell, Anaplastic (drug therapy, therapy)
  • Male
  • Middle Aged
  • Prednisolone (administration & dosage)
  • Stem Cell Transplantation
  • Transplantation, Autologous
  • Treatment Outcome
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: